UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial

European urology, 2022-03, Vol.81 (3), p.234-240

2022

Volltextzugriff (PDF)

Sequential emergence of ABL-kinase mutations with loss of unmutated BCR-ABL allele during targeted therapies of CML

Blood, 2006-09, Vol.108 (5), p.1782-1783

2006

Volltextzugriff (PDF)

Abstract OT-13-05: Dolaf- an international multicenter phase 2 trial of durvalumab (medi4736) plus olaparib plus fulvestrant in metastatic or locally advanced er-positive, her2-negative breast cancer patients selected using criteria that predict sensitivity to olaparib (UCBG308)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-13-05-OT-13-05

2021

Volltextzugriff (PDF)

Abstract PS12-05: First efficacy results of a 2-stage Simon’s design randomised phase 2 of darolutamide or capecitabine in patients with triple-negative, androgen receptor positive advanced breast cancer (UCBG06-3)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS12-05-PS12-05

2021

Volltextzugriff (PDF)

ODENZA: A study of patient preference between ODM-201 (darolutamide) and enzalutamide in men with metastatic castrate-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.TPS334-TPS334

2019

Volltextzugriff (PDF)

ODENZA: A study of patient preference between ODM-201 (darolutamide) and enzalutamide in men with metastatic castrate-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS5093-TPS5093

2018

Volltextzugriff (PDF)

Final results from the randomized CABADOC trial: Patient preference between cabazitaxel and docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5017-5017

2019

Volltextzugriff (PDF)

GEFCAPI 04: A phase III trial comparing a treatment oriented by a molecular analysis with CancerTYPE ID test to cisplatin-gemcitabine in patients with carcinoma of an unknown primary (CUP)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS11134-TPS11134

2014

Volltextzugriff (PDF)

No Evidence for Increased Transplant Related Complications in Ph+ Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia with Prior Treatment with Dasatinib

Blood, 2006-11, Vol.108 (11), p.2975-2975

2006

Volltextzugriff (PDF)

Immunotherapy in Chronic Myelogenous Leukemia

Clinical lymphoma & myeloma, 2007-03, Vol.7, p.S64-S70

2007

Volltextzugriff (PDF)

helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis

Proceedings of the National Academy of Sciences - PNAS, 2009-12, Vol.106 (52), p.22217-22222

2009

Volltextzugriff (PDF)

Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process

Frontiers in microbiology, 2019-04, Vol.10 (792), p.792-792

2019

Volltextzugriff (PDF)

Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension

Thorax, 2022-03, Vol.77 (3), p.247-258

2022

Volltextzugriff (PDF)

Neurite density is reduced in the presymptomatic phase of C9orf72 disease

Journal of neurology, neurosurgery and psychiatry, 2019-04, Vol.90 (4), p.387-394

2019

Volltextzugriff (PDF)

Abstract 15621: Checkpoint Kinases Important Players in Lung Fibrogenesis and Pulmonary Vascular Remodeling: A Translational Study

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A15621-A15621

2020

Volltextzugriff (PDF)

Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

Neurobiology of aging, 2019-02, Vol.74, p.234.e1-234.e8

2019

Volltextzugriff (PDF)

A mixed grape and blueberry extract is safe for dogs to consume

BMC veterinary research, 2016-08, Vol.12 (1), p.162-162, Article 162

2016

Volltextzugriff (PDF)

Glycolysis Dependency as a Hallmark of SF3B1 -Mutated Cells

Cancers, 2022-04, Vol.14 (9), p.2113

2022

Volltextzugriff (PDF)

Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis

Journal of neurology, neurosurgery and psychiatry, 2021-05, Vol.92 (5), p.485-493

2021

Volltextzugriff (PDF)

Cognitive inhibition impairments in presymptomatic C9orf72 carriers

Journal of neurology, neurosurgery and psychiatry, 2020-04, Vol.91 (4), p.366-372

2020

Volltextzugriff (PDF)

Abstract 15922: Sensitize Pulmonary Artery Smooth Muscle Cells (PASMC) to Oxidative Stress by 8oxoguanine Hydrolase Nudt1 Inhibition Has a Therapeutic Potential in Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A15922-A15922

2019

Volltextzugriff (PDF)

Comment rapatrier l'argent volé par les dictateurs africains?

Jeune Afrique économie (1986), 1991-12, p.164-171

1991

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(23)

Sprache

Englisch
(22)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Humans
(8)
Life Sciences
(5)
Mutation
(5)
Neurosciences & Neurology
(5)
Amyotrophic Lateral Sclerosis
(4)
Psychiatry
(4)
Animals
(3)
Clinical Neurology
(3)
Dementia
(3)
Female
(3)
Male
(3)
Surgery
(3)
Adult
(2)
Age
(2)
Aged
(2)
Amyotrophic Lateral Sclerosis - Genetics
(2)
Benzamides
(2)
Biomarkers - Blood
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial

Sequential emergence of ABL-kinase mutations with loss of unmutated BCR-ABL allele during targeted therapies of CML

Abstract OT-13-05: Dolaf- an international multicenter phase 2 trial of durvalumab (medi4736) plus olaparib plus fulvestrant in metastatic or locally advanced er-positive, her2-negative breast cancer patients selected using criteria that predict sensitivity to olaparib (UCBG308)

Abstract PS12-05: First efficacy results of a 2-stage Simon’s design randomised phase 2 of darolutamide or capecitabine in patients with triple-negative, androgen receptor positive advanced breast cancer (UCBG06-3)

ODENZA: A study of patient preference between ODM-201 (darolutamide) and enzalutamide in men with metastatic castrate-resistant prostate cancer (mCRPC)

ODENZA: A study of patient preference between ODM-201 (darolutamide) and enzalutamide in men with metastatic castrate-resistant prostate cancer (mCRPC)

Final results from the randomized CABADOC trial: Patient preference between cabazitaxel and docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC)

GEFCAPI 04: A phase III trial comparing a treatment oriented by a molecular analysis with CancerTYPE ID test to cisplatin-gemcitabine in patients with carcinoma of an unknown primary (CUP)

No Evidence for Increased Transplant Related Complications in Ph+ Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia with Prior Treatment with Dasatinib

Immunotherapy in Chronic Myelogenous Leukemia

helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis

Antimicrobial Usages and Antimicrobial Resistance in Commensal Escherichia coli From Veal Calves in France: Evolution During the Fattening Process

Genome-wide analysis of gene dosage in 24,092 individuals estimates that 10,000 genes modulate cognitive ability

Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension

Neurite density is reduced in the presymptomatic phase of C9orf72 disease

Abstract 15621: Checkpoint Kinases Important Players in Lung Fibrogenesis and Pulmonary Vascular Remodeling: A Translational Study

Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

A mixed grape and blueberry extract is safe for dogs to consume

Glycolysis Dependency as a Hallmark of SF3B1 -Mutated Cells

Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis

Cognitive inhibition impairments in presymptomatic C9orf72 carriers

Abstract 15922: Sensitize Pulmonary Artery Smooth Muscle Cells (PASMC) to Oxidative Stress by 8oxoguanine Hydrolase Nudt1 Inhibition Has a Therapeutic Potential in Pulmonary Arterial Hypertension

Comment rapatrier l'argent volé par les dictateurs africains?

Suchergebnisse filtern